NCT06282731View on ClinicalTrials.gov

The Changes of Urine Growth Factors Level

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 1, 2016

Study Completion Date

April 27, 2017

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Silodosin

Indications:Benign prostate hyperplasia

Trial Locations (1)

23702

En Chu Kong Hospital, New Taipei City

All Listed Sponsors
lead

En Chu Kong Hospital

OTHER

NCT06282731 - The Changes of Urine Growth Factors Level | Biotech Hunter | Biotech Hunter